Analyst consensus rating
Cabaletta Bio Analyst Rating: none
Direct answer
Cabaletta Bio's consensus rating is none.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.25.
Forecast evidence checked October 2, 2026.
Get free Cabaletta Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.87
- Average price target
- $13.25
- High price target
- $30.00
- Low price target
- $3.00
- Low target gap
- +60.4%
- Target upside
- +608.6%
- High target gap
- +1,504.3%
- Target range width
- 1,443.9%
- Consensus rating
- none
- Analysts
- 8
- Evidence date
- October 2, 2026
- Valid through
- October 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cabaletta Bio?
Cabaletta Bio has a verified none consensus. The same dataset has an average price target of $13.25.
How far are Cabaletta Bio's low and high targets from the recorded price?
The low target implies +60.4%, while the high target implies +1,504.3%.
How many analysts are included in Cabaletta Bio's consensus?
The verified consensus includes 8 analysts.
How is Cabaletta Bio's target upside or downside calculated?
The average target of $13.25 is divided by the recorded price of $1.87, then one is subtracted to produce +608.6%. This does not guarantee a future return.
When was Cabaletta Bio's analyst forecast verified?
The data was verified on 2026-10-02. The dataset is valid through 2026-10-09.